of page followers and likes (Table I) . With health care quality being increasingly emphasized, practices should utilize the unique QI information available on social media and consider its role in the proactive surveillance of patient feedback. As use of social media continues to grow, we should remain mindful of its influence and take advantage of the opportunities that it offers to shape health care in new ways.
Effect of petrolatum coating on fast-absorbing gut suture
To the Editor: The choice of epidermal suture is largely a stylistic choice by surgeons, as numerous studies have found equivalent outcomes from nonabsorbable sutures removed after 5 days, long-acting absorbable sutures removed after 5 days, 1, 2 and rapidly absorbable sutures that are not removed. 3 Fast-absorbing gut sutures are often used in dermatologic surgery on the face but are commonly coated with petrolatum 4 to improve tissue-handling characteristics. The effect of this on the absorption in vivo has not been studied and is unknown, and petrolatum is an added inert substance that might blunt the necessary inflammatory degradation of the suture. We observed a wide variety of time to suture absorption within our institution during postoperative evaluation of patients and noted that petrolatum coating was intermittently performed on the basis of surgeon preference. We hypothesized that the petrolatum coating might be delaying the absorption of the suture.
To assess the effect of petrolatum, we designed a single-blind controlled study in which a 6-0 fast-absorbing gut suture was placed into 2 sites on the arms of healthy adults, 1 site involving a petrolatum-coated suture. After approval by the 59th Medical Wing Institutional Review Board ( protocol FWH20160040H, approved January 2016) and individual informed consent, 14 healthy adults ranging in age from 29-46 years agreed to participate. The skin on the nondominant arm overlying the deltoid was cleaned and anesthetized in the usual fashion. In an effort to limit variables to the effect of the petrolatum, no incision was performed. Two 6-0 fast-absorbing gut sutures were placed, 1 coated with petrolatum and 1 not coated with petrolatum (control) in a randomized order blinded to the patient. The suture was tied with a secure knot but loosely tensioned to not contract the skin. The sites were kept protected using sterile film dressings with a nonstick gauze pad and could be evaluated by the participants by rolling cotton tipped applicators over the sutures. No further petrolatum was applied to the wound. The study participants recorded the time when the suture knot spontaneously fell out of the surface of the skin.
We found no statistically significant difference in absorption time between the petrolatum-coated and nonpetrolatumecoated sutures, with coated sutures lasting an average of 223 hours (9.3 days) and plain sutures lasting an average of 208 hours (8.7 days; P ¼ .51). A wide variety of absorption times was observed across both groups (Table I) , ranging 66-403 hours (2.8-16.8 days). There was no association between participant age with time to suture absorption. No study participants experienced any scarring or other complications.
In conclusion, petrolatum coating did not significantly affect the absorption time. This study might be limited somewhat by sample size and participants self-reporting the data, but of clinical significance was the wide variability of absorption times from person to person, which was likely due to the organic nature of the suture itself. Maintenance of therapeutic response after 1 year of apremilast combination therapy compared with monotherapy for the treatment of plaque psoriasis: A multicenter, retrospective study To the Editor: Apremilast monotherapy has generated considerable excitement as an oral option for the treatment of psoriasis because of its favorable efficacy and safety profile based on its pivotal randomized controlled trials, ESTEEM 1 and 2.
1,2 In real-world practice, it is sometimes used in combination with biologic agents and conventional systemic agents to control residual psoriasis that cannot be managed with 1 agent alone. Our research group previously published our findings comparing the efficacy and safety of apremilast monotherapy with combination therapy during an initial 16-week treatment phase in real-world 
